286 related articles for article (PubMed ID: 11181402)
21. Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature.
Guan Z; Singletary ST; Cook AK; Hobbs JL; Pollock JS; Inscho EW
J Am Soc Nephrol; 2014 Aug; 25(8):1774-85. PubMed ID: 24578134
[TBL] [Abstract][Full Text] [Related]
22. Renal cortical and medullary microvascular blood flow autoregulation in rat.
Harrison-Bernard LM; Navar LG
Kidney Int Suppl; 1996 Dec; 57():S23-9. PubMed ID: 8941918
[TBL] [Abstract][Full Text] [Related]
23. Role of adenosine receptor subtypes in rat jejunum in unfed state versus glucose-induced hyperemia.
Li N; Harris PD; Zakaria el R; Matheson PJ; Garrison RN
J Surg Res; 2007 May; 139(1):51-60. PubMed ID: 17291535
[TBL] [Abstract][Full Text] [Related]
24. Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.
Zhao X; Cook AK; Field M; Edwards B; Zhang S; Zhang Z; Pollock JS; Imig JD; Inscho EW
Hypertension; 2005 Sep; 46(3):562-8. PubMed ID: 16116048
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses.
Imig JD; Pham BT; LeBlanc EA; Reddy KM; Falck JR; Inscho EW
Hypertension; 2000 Jan; 35(1 Pt 2):307-12. PubMed ID: 10642316
[TBL] [Abstract][Full Text] [Related]
26. Biphasic actions of prostaglandin E(2) on the renal afferent arteriole : role of EP(3) and EP(4) receptors.
Tang L; Loutzenhiser K; Loutzenhiser R
Circ Res; 2000 Mar; 86(6):663-70. PubMed ID: 10747002
[TBL] [Abstract][Full Text] [Related]
27. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus.
Schoonmaker GC; Fallet RW; Carmines PK
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F302-9. PubMed ID: 10662734
[TBL] [Abstract][Full Text] [Related]
28. Direct assessment of renal microvascular responses to P2-purinoceptor agonists.
Inscho EW; Cook AK; Mui V; Miller J
Am J Physiol; 1998 Apr; 274(4):F718-27. PubMed ID: 9575896
[TBL] [Abstract][Full Text] [Related]
29. Determinants of renal microvascular response to ACh: afferent and efferent arteriolar actions of EDHF.
Wang X; Loutzenhiser R
Am J Physiol Renal Physiol; 2002 Jan; 282(1):F124-32. PubMed ID: 11739120
[TBL] [Abstract][Full Text] [Related]
30. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways.
Imig JD; Navar LG
Am J Physiol; 1996 Jul; 271(1 Pt 2):F87-93. PubMed ID: 8760247
[TBL] [Abstract][Full Text] [Related]
31. In vivo effects of diadenosine polyphosphates on rat renal microcirculation.
Gabriëls G; Endlich K; Rahn KH; Schlatter E; Steinhausen M
Kidney Int; 2000 Jun; 57(6):2476-84. PubMed ID: 10844616
[TBL] [Abstract][Full Text] [Related]
32. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
Munger KA; Jackson EK
Am J Physiol; 1994 Nov; 267(5 Pt 2):F783-90. PubMed ID: 7977781
[TBL] [Abstract][Full Text] [Related]
33. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension.
Imig JD
Am J Hypertens; 2000 Jul; 13(7):810-8. PubMed ID: 10933574
[TBL] [Abstract][Full Text] [Related]
34. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction.
Inscho EW; Cook AK; Mui V; Imig JD
Hypertension; 1998 Jan; 31(1 Pt 2):421-8. PubMed ID: 9453339
[TBL] [Abstract][Full Text] [Related]
35. Efferent arteriole tubuloglomerular feedback in the renal nephron.
Ren Y; Garvin JL; Carretero OA
Kidney Int; 2001 Jan; 59(1):222-9. PubMed ID: 11135074
[TBL] [Abstract][Full Text] [Related]
36. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Saruta T
Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure.
Ichihara A; Imig JD; Navar LG
Hypertension; 1999 Oct; 34(4 Pt 2):843-7. PubMed ID: 10523371
[TBL] [Abstract][Full Text] [Related]
38. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin.
Imig JD; Falck JR; Wei S; Capdevila JH
J Vasc Res; 2001; 38(3):247-55. PubMed ID: 11399897
[TBL] [Abstract][Full Text] [Related]
39. Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor.
Shepherd RK; Linden J; Duling BR
Circ Res; 1996 Apr; 78(4):627-34. PubMed ID: 8635220
[TBL] [Abstract][Full Text] [Related]
40. Disparate effects of calcium antagonists on renal microcirculation.
Hayashi K; Nagahama T; Oka K; Epstein M; Saruta T
Hypertens Res; 1996 Mar; 19(1):31-6. PubMed ID: 8829821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
